Results 211 to 220 of about 84,856 (259)

Sclerosing cholangitis

Baillière's Clinical Gastroenterology, 1997
Primary sclerosing cholangitis (PSC) is a chronic, progressive cholestatic liver disease whose aetiopathogenesis is unknown. PSC is frequently associated with inflammatory bowel disease, in particular chronic ulcerative colitis, is most commonly observed in young males and is clinically characterized by fatigue, pruritus and jaundice.
P J, Marotta, N F, LaRusso, R H, Wiesner
openaire   +2 more sources

Primary Sclerosing Cholangitis

Gastroenterology Nursing, 2007
Primary sclerosing cholangitis is a chronic cholestatic liver disease of unknown origin characterized by progressive inflammation, destruction, and fibrosis of the intrahepatic and extrahepatic bile ducts. The disease leads to obliteration of intrahepatic bile ducts and to biliary cirrhosis, end-stage liver disease, and portal hypertension.
Konstantinos N. Lazaridis, James H. Tabibian, Nicholas F. LaRusso   +2 more
openaire   +4 more sources

Secondary Sclerosing Cholangitis: A Comparison to Primary Sclerosing Cholangitis

The American Journal of Gastroenterology, 2005
The natural history of secondary sclerosing cholangitis (SSC) is ill-defined. In order to better determine the natural history of this condition, we retrospectively reviewed data from the Mayo Clinic in Rochester, Minnesota. We also compared the natural history of patients diagnosed with SSC to a cohort with a diagnosis of primary sclerosing ...
Paul Angulo, Keith D. Lindor, Andrea A. Gossard   +2 more
openaire   +3 more sources

Pregnancy outcomes in women with primary biliary cholangitis and primary sclerosing cholangitis: a retrospective cohort study

BJOG: an International Journal of Obstetrics and Gynaecology, 2020
To determine maternal, obstetric and neonatal outcomes in a cohort of women with primary biliary cholangitis (PBC) and primary sclerosing cholangitis (PSC).
M. Cauldwell, F. Mackie, P. Steer, Michael A Henehghan, Jelle H Baalman, J. Brennand, T. Johnston, S. Dockree, C. Hedley, S. Jarvis, S. Khan, F. Mcauliffe, L. Mackillop, L. Penna, Belinda Smith, P. Trivedi, S. Verma, R. Westbrook, Sarah Winifield, C. Williamson   +19 more
semanticscholar   +1 more source

Epidemiological features of immunoglobulin G4‐related sclerosing cholangitis in Japan

Journal of hepato-biliary-pancreatic sciences, 2020
Epidemiological data on immunoglobulin G4‐related sclerosing cholangitis (IgG4‐SC) are scarce.
A. Tanaka, Mitsuru Mori, K. Kubota, I. Naitoh, T. Nakazawa, H. Takikawa, M. Unno, T. Kamisawa, S. Kawa, K. Okazaki   +9 more
semanticscholar   +1 more source

Primary sclerosing cholangitis

The Lancet, 2018
Primary sclerosing cholangitis is a rare, chronic cholestatic liver disease characterised by intrahepatic or extrahepatic stricturing, or both, with bile duct fibrosis. Inflammation and fibrosis of bile ducts and the liver are followed by impaired bile formation or flow and progressive liver dysfunction.
Dyson JK, Beuers U, Jones DEJ, Lohse AW, Hudson M   +4 more
openaire   +4 more sources

Fecal Microbiota Transplantation in Patients With Primary Sclerosing Cholangitis: A Pilot Clinical Trial.

American Journal of Gastroenterology, 2019
BACKGROUND Primary sclerosing cholangitis (PSC) is a cholestatic liver disease with no effective medical therapies. A perturbation of the gut microbiota has been described in association with PSC, and fecal microbiota transplantation (FMT) has been ...
J. Allegretti, Z. Kassam, Madeline Carrellas, B. Mullish, J. Marchesi, A. Pechlivanis, Mark Smith, Y. Gerardin, Sonia C. Timberlake, D. Pratt, J. Korzenik   +10 more
semanticscholar   +1 more source

Secondary sclerosing cholangitis

Nature Reviews Gastroenterology & Hepatology, 2009
Secondary sclerosing cholangitis (SSC) is a chronic cholestatic biliary disease, characterized by inflammation, obliterative fibrosis of the bile ducts, stricture formation and progressive destruction of the biliary tree that leads to biliary cirrhosis.
Petra Ruemmele, Cornelia M. Gelbmann, Ferdinand Hofstaedter   +2 more
openaire   +3 more sources

Primary sclerosing cholangitis

Current Treatment Options in Gastroenterology, 2001
There is no proven medical therapy for primary sclerosing cholangitis. The goal of management should be treatment of symptoms and complications of cholestasis, as well as attempts at treating the underlying disease process. In addition, efforts should be made to recognize and treat or prevent the known complications of primary sclerosing cholangitis ...
David J. Kim, Young Mee Lee
openaire   +3 more sources

EASL Clinical Practice Guidelines on Sclerosing Cholangitis.

Journal of Hepatology, 2022
O. Chazouilleres, U. Beuers, A. Bergquist, T. Karlsen, C. Levy, M. Samyn, C. Schramm, M. Trauner   +7 more
semanticscholar   +1 more source